NCT07200830 2025-10-01
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Alliance for Clinical Trials in Oncology
Phase 3 Not yet recruiting
Clinical Trials
5 trialsNCT06922903 2025-04-13
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 3 Not yet recruiting
NCT06855589 2025-03-04
PCS-XII
Charles LeMoyne Hospital
Phase 3 Not yet recruiting
NCT06837896 2025-02-20
Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT05232578 2022-08-03
ESTABLISH
General University Hospital, Prague
Phase 3 Not yet recruiting